Pembrolizumab (pembro) combination therapies in patients with metastatic castration-resistant prostate cancer (mCRPC): Cohorts A-C of the phase Ib/II KEYNOTE-365 study

AM Joshua, H Gurney, M Retz, A Tafreshi, PCC Fong, ND Shore, E Romano, Marinela Augustin, JM Piulats, WR Berry, MP Kolinsky, SS Sridhar, HJ Conter, T Todenhofer, LJ Appleman, H Wu, C Schloss, CH Poehlein, JS de Bono, EY Yu

Research output: Contribution to journalpublished Abstract (Journal)peer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)S1325-S1325
JournalANNALS OF ONCOLOGY
Volume31
DOIs
Publication statusPublished - 2020
EventESMO Asia Virtual Congress - ELECTR NETWORK
Duration: 20 Nov 202022 Nov 2020

Cite this